We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Latest News
Physicists Report Advance Toward a Nanotechnology Approach to Protein Engineering
News

Physicists Report Advance Toward a Nanotechnology Approach to Protein Engineering

Researchers are learning to control proteins in a new way.
PDS Announces Expanded Licensing Options for the Web-Based, Hosted Applicaton Choices
News

PDS Announces Expanded Licensing Options for the Web-Based, Hosted Applicaton Choices

Additional licensing options to meet wider needs of University research departments, CROs, Biotechs and smaller Toxicology and Pathology work groups.
LabCorp® and Duke University Collaborate to Offer Genomic Tests
News

LabCorp® and Duke University Collaborate to Offer Genomic Tests

The program will support advanced research studies in specified clinical testing applications in genomic medicine.
Cambrex and Cytori Enter into Collaboration
News

Cambrex and Cytori Enter into Collaboration

Companies to provide adipose derived stem cell research products.
Covance Announces the Acquisition of Signet Laboratories
News

Covance Announces the Acquisition of Signet Laboratories

Covance acquires substantially all of the assets of Signet Laboratories.
Carrington Receives European Patent Protection for Stabilization of Proteins and Peptides
News

Carrington Receives European Patent Protection for Stabilization of Proteins and Peptides

Focuses on stabilization of unstable molecules expands drug delivery base for proteins and peptides.
Sigma-Aldrich and Oxford BioMedica File Suit Against Open Biosystems
News

Sigma-Aldrich and Oxford BioMedica File Suit Against Open Biosystems

Both companies pursue protection of RNAi-related intellectual property.
CytoGenix Receives Re-Supply Order for synDNA™
News

CytoGenix Receives Re-Supply Order for synDNA™

The current order for synDNA™ was placed after the initial batch of synDNA™ proved to be the preferred material.
SemBioSys Obtains Rights to Platform-Enhancing Technologies from Syngenta
News

SemBioSys Obtains Rights to Platform-Enhancing Technologies from Syngenta

The agreement provides SemBioSys with a license to Syngenta's proprietary safflower transformation technology.
Invitrogen and Solexa Collaborate to Supply Reagents for Next Generation Sequencing
News

Invitrogen and Solexa Collaborate to Supply Reagents for Next Generation Sequencing

Invitrogen reagents among those to be used in kits for Solexa Genome Analysis System.
Advertisement